埃索美拉唑的全球专利申请状况分析

47CHINAINVENTION&PATENTStatistics&AnalysisFDA410200982STNCPRSSTNANALYZEIPCROLECTTIPA2012131119942001930200220061402/48CHINAINVENTION&PATENTStatistics&AnalysisPCT13IPCSTNREGISTRYCASNOCAPLUSCASNOEXCEL154332A61KC07D95%A61K74%//439953728228873216662036219061182581814849CHINAINVENTION&PATENTStatistics&Analysis1200010US6875872B1200122419942007S19992009199920001199420101996199820031998200020022006200620072008200921US569096020141125US5690960*PED20155252US58771922014527US5877192*PED201411273US68758722014527US6875872*PED201411274US5714504201523US5714504*PED2015835US5900424201654US5900424*PED20161146US63690852018525US6369085*PED201811257US74110702018525US7411070*PED201811258US61471032018109US6147103*PED2019499US61662132018109US6166213*PED20194910US61911482018109US6191148*PED20194911US64288102019113US6428810*PED202053*US6191148B1S-S-20039US7411070S-50CHINAINVENTION&PATENTStatistics&Analysis19995US5900424X-70%2--19993US5877192A--319947US5690960AX-70%pH19951US5714504A--HPC38HPC199911US6428810B14/200011US614710320ppm5S-S-S-FI-IP19985S-US6369085B16pyrmetazolepyrmetazole-200012US6166213US6166213US6147103